Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



GSK's Withdrawn Myeloma Drug Could Receive Combo Approval

November 27, 2024
Pharmaceutical company GSK is considering seeking combination approval for a previously withdrawn drug used in the treatment of multiple myeloma. The drug, which was withdrawn due to safety concerns, has shown promising results in recent studies and could potentially have a significant impact on the treatment of this rare form of cancer. GSK is exploring options to reintroduce the drug in combination with other therapies in order to increase its efficacy and safety profile. Investors are recommended to consult professionals from Stocks Prognosis for a forecast on the movement of GSK's stocks.
If you want to leave a comment, then you need Login or Register





Other data for GSK

Related data

GSKJuly 17, 2025QuantWave Successfully Predicts GSK PLC Stock Movement, Achieving 7.53% Profit  ~2 min.

QuantWave, the automated forecasting platform, has once again proven its accuracy with the successful prediction of the price movement of GSK PLC stock....


GSKJuly 17, 2025QuantWave Hits Bullseye with GSK PLC Forecast, Achieving 7.53% Profit  ~2 min.

On May 27, 2025, QuantWave, the automated forecasting platform, issued a short signal for GSK PLC with a price target of 36.07 $. The stock was trading at 39....


GSKJune 12, 2025QuantWave Achieves 14.92% Profit Target Forecast for GSK PLC  ~1 min.

QuantWave, the automated forecasting platform, successfully reached a price target forecast for GSK PLC, yielding a profit of 14.92%....


GSKJune 12, 2025QuantWave Successfully Achieves 10.55% Profit Target Forecast for GSK PLC  ~2 min.

QuantWave, the automated forecasting platform, has recently hit a milestone with its accurate prediction for the stock of GSK PLC....


GSKJune 12, 2025QuantWave Hits Bullseye with GSK PLC Forecast, Generating 9.06% Profit  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has once again demonstrated its accuracy with an impressive 9.06% profit on the stock of GSK PLC....


GSKJune 12, 2025QuantWave Forecast Hits the Mark: GSK PLC Stock Reaches Price Target with 9.53% Profit  ~2 min.

On March 21, 2025, QuantWave, the automated forecasting platform, issued a long signal for GSK PLC stock when it was trading at $38.37. Fast forward to June 12, 2025, the predicted target of $42....


GSKJune 12, 2025QuantWave Hits Price Target Forecast for GSK PLC with 7.32% Profit  ~2 min.

On March 7, 2025, QuantWave, an automated forecasting platform, successfully forecasted a price target for the stock GSK PLC. The signal indicated a long position when the stock was trading at 39.16 $....


GSKJune 12, 2025QuantWave Successfully Predicts GSK PLC Stock Price, Generating 11.84% Profit  ~1 min.

On March 4th, 2025, QuantWave, the automated forecasting platform, issued a long signal for GSK PLC stock at a price of $37.58....


GSKJune 12, 2025QuantWave Forecasts Success: GSK PLC Hits Price Target with 8.84% Profit  ~1 min.

On March 14, 2025, QuantWave, an automated forecasting platform, issued a long signal for the stock of GSK PLC at a price of 38.61 $. Fast forward to June 12, 2025, the target price of 42....


GSKJune 12, 2025QuantWave Achieves 8.81% Profit Target Forecast for GSK PLC Stock  ~1 min.

QuantWave, the automated forecasting platform, successfully reached its price target forecast for GSK PLC stock, with a profit margin of 8.81%....


VRTXMarch 22, 2025Vertex Pharmaceuticals VRTX: One of the Best Biotech Stocks to Buy According to Billionaires  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been recognized as one of the top biotech stocks to invest in by billionaires....


REGNJanuary 3, 2025Regeneron Pharmaceuticals: A Promising Future with Strong Returns  ~2 min.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been making waves in the pharmaceutical industry with its groundbreaking research and innovative treatments....


VRTXJanuary 12, 2025Vertex Pharmaceuticals Incorporated Faces Setbacks in Clinical Trials  ~1 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares experienced a slide recently due to setbacks in its clinical trials....


PFENovember 21, 2024Pfizer Inc. Introduces Groundbreaking Immunotherapy Treatment, Boosting Confidence in PFE Stock  ~2 min.

Pfizer Inc., a leading pharmaceutical company, has announced the development of a groundbreaking immunotherapy treatment that could revolutionize cancer treatment....


GSKNovember 28, 2024GSK submits multiple myeloma treatment for approval to the US regulator  ~1 min.

GSK, a leading pharmaceutical company, has recently submitted its groundbreaking treatment for multiple myeloma to the US regulator for approval....